Littleton, CO and Seattle, WA – July 1, 2012
dBMEDx™, Inc., a privately-held automated wireless medical device company, has received a patent for its 3D ultrasound technology.
Patent No. 8,206,307, issued by the U.S. Patent and Trademark Office, provides the company with market exclusivity for products using scan-engine design through 2032. dBMEDx™ has created a new, compact 3D ultrasound device that enables extremely powerful 3D image collection, analysis and automated diagnosis requiring little or no ultrasound expertise from the user.
The patent application was fast-tracked through the USPTO using the Patent Prosecution Highway pathway and issued just 22 months after the initial application date.
“The technology covered by this patent is at the heart of our products, and we worked intentionally to fast track the patent application through the approval process.” said David Shine, chief executive of dBMEDx™. “The strength of the claims and the speed of the approval are a testament to the novelty and value of our architecture.”
The patent describes a compact ultrasound apparatus that is entirely self-contained, battery powered and wirelessly connected to an external display platform or mobile device. The company has a number of devices in the development pipeline that will use the technology, including an automated bladder-volume measurement device and an automated critical-care device for diagnosis of sepsis and other pathologies.
About dBMEDx, Inc.
dBMEDx is a medical device company that is developing novel, automated scanning devices for a wide range of medical applications. The company has developed the world’s smallest, wireless 3D ultrasound scan engine with integrated image analysis capability. This device architecture overcomes many of the limitations of traditional imaging technology to create devices that can be used with very little training by any medical professional. The patented dBMEDx architecture automatically collects and analyzes the image data and wirelessly presents the user with a numeric result, bringing the power and safety of ultrasound-based diagnosis to all medical professionals. For additional information, please visit www.dBMEDx.com.
David Shine, CEO